Literature DB >> 8413283

Transcriptional control of the chicken cardiac myosin light-chain gene is mediated by two AT-rich cis-acting DNA elements and binding of serum response factor.

N Papadopoulos1, M T Crow.   

Abstract

Transcriptional control of the cardiac/slow skeletal alkali myosin light-chain (MLC1c/1s) gene is mediated, in part, by two highly conserved AT-rich cis-acting elements present in the immediate 5' flanking region. These elements cooperate to form an enhancer that can impart tissue specificity to heterologous promoters that are themselves not tissue specific in their pattern of expression. In the chicken, one of these elements matches the binding site for myocyte-specific enhancer-binding factor 2, while the other is a cis-acting element present in the transcriptional control regions of all striated alkali MLC genes (except MLC3f) and is referred to as the MLC box. The central decanucleotide core region of the MLC box closely resembles the CArG (CC[A/T]6GG) box of the serum response element, and the binding of muscle nuclear protein complexes to this element can be competed for with a synthetic serum response element. On the basis of their competition profiles and requirements for nonspecific competitor, two nuclear protein complexes, which compete for binding to the CArG-like region of the MLC box, have been identified. One of the complexes binds to a mutation of the CArG-like region that inactivates transcription of a linked reporter gene, while binding of the other complex is inhibited by this mutation. This latter complex reacts with an antibody to serum response factor (SRF) and exhibits the same binding characteristics as purified SRF. These results demonstrate that transcriptional control of the chicken MLC1c/1s gene resides in an upstream enhancer that is composed of two separate AT-rich elements, both of which are required to drive expression of a linked reporter gene. The binding of a nuclear protein complex containing SRF to one of these elements, the MLC box, is required for gene activation and apparently inhibited by other nuclear factors whose binding overlaps that of the SRF complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413283      PMCID: PMC364753          DOI: 10.1128/mcb.13.11.6907-6918.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

Review 1.  The serum response element.

Authors:  R Treisman
Journal:  Trends Biochem Sci       Date:  1992-10       Impact factor: 13.807

2.  A combination of closely associated positive and negative cis-acting promoter elements regulates transcription of the skeletal alpha-actin gene.

Authors:  K L Chow; R J Schwartz
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

3.  A protocol for using T7 DNA polymerase in oligonucleotide site-directed mutagenesis.

Authors:  C Zhou; L Abaigar; A Y Jong
Journal:  Biotechniques       Date:  1990-05       Impact factor: 1.993

4.  The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation.

Authors:  V M Rivera; M Sheng; M E Greenberg
Journal:  Genes Dev       Date:  1990-02       Impact factor: 11.361

5.  Casein kinase II enhances the DNA binding activity of serum response factor.

Authors:  J R Manak; N de Bisschop; R M Kris; R Prywes
Journal:  Genes Dev       Date:  1990-06       Impact factor: 11.361

6.  Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes.

Authors:  K Walsh
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

7.  Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1.

Authors:  V Sartorelli; K A Webster; L Kedes
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

8.  CC Ar GG boxes, cis-acting elements with a dual specificity. Muscle-specific transcriptional activation and serum responsiveness.

Authors:  D Tuil; N Clergue; D Montarras; C Pinset; A Kahn; F Phan-Dinh-Tuy
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

9.  Regulation of the chicken embryonic myosin light-chain (L23) gene: existence of a common regulatory element shared by myosin alkali light-chain genes.

Authors:  T Uetsuki; Y Nabeshima; A Fujisawa-Sehara; Y Nabeshima
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

10.  Muscle-specific (CArG) and serum-responsive (SRE) promoter elements are functionally interchangeable in Xenopus embryos and mouse fibroblasts.

Authors:  M Taylor; R Treisman; N Garrett; T Mohun
Journal:  Development       Date:  1989-05       Impact factor: 6.868

View more
  10 in total

1.  Cell-specific transcription of the smooth muscle gamma-actin gene requires both positive- and negative-acting cis elements.

Authors:  A M Kovacs; W E Zimmer
Journal:  Gene Expr       Date:  1998

2.  Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts.

Authors:  C Gauthier-Rouviere; M Vandromme; D Tuil; N Lautredou; M Morris; M Soulez; A Kahn; A Fernandez; N Lamb
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

3.  Transcriptional regulation of the Papilio polyxenes CYP6B1 gene.

Authors:  H Prapaipong; M R Berenbaum; M A Schuler
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

4.  A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene.

Authors:  F Catala; R Wanner; P Barton; A Cohen; W Wright; M Buckingham
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

5.  Serum response factor and protein-mediated DNA bending contribute to transcription of the dystrophin muscle-specific promoter.

Authors:  F Galvagni; M Lestingi; E Cartocci; S Oliviero
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells.

Authors:  Gerhard Schratt; Ulrike Philippar; Jürgen Berger; Heinz Schwarz; Olaf Heidenreich; Alfred Nordheim
Journal:  J Cell Biol       Date:  2002-02-11       Impact factor: 10.539

7.  SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.

Authors:  Dali Li; Zhiyv Niu; Weishi Yu; Yu Qian; Qian Wang; Qiang Li; Zhengfang Yi; Jian Luo; Xiushan Wu; Yuequn Wang; Robert J Schwartz; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

8.  Transcription of the human beta enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors.

Authors:  S Feo; V Antona; G Barbieri; R Passantino; L Calì; A Giallongo
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

9.  Ena/VASP is required for endothelial barrier function in vivo.

Authors:  Craig Furman; Alisha L Sieminski; Adam V Kwiatkowski; Douglas A Rubinson; Eliza Vasile; Roderick T Bronson; Reinhard Fässler; Frank B Gertler
Journal:  J Cell Biol       Date:  2007-11-12       Impact factor: 10.539

10.  SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis.

Authors:  Xiangli Ye; Yu Qian; Qian Wang; Wuzhou Yuan; Xiaoyang Mo; Yongqing Li; Zhigang Jiang; Wei Xu; Yun Deng; Yongqi Wan; Xiongwei Fan; Xiushan Wu; Yuequn Wang
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.